486 related articles for article (PubMed ID: 16840428)
1. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
2. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
[TBL] [Abstract][Full Text] [Related]
4. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
Tsuji BT; Rybak MJ; Cheung CM; Amjad M; Kaatz GW
Diagn Microbiol Infect Dis; 2007 May; 58(1):41-7. PubMed ID: 17300912
[TBL] [Abstract][Full Text] [Related]
5. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
6. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
Vonk AG; Vandenbroucke-Grauls CM
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):401-7. PubMed ID: 17343138
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
Saravolatz LD; Pawlak J; Johnson LB
J Antimicrob Chemother; 2007 Aug; 60(2):406-9. PubMed ID: 17586562
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and clonal relatedness between community- and hospital-acquired methicillin-resistant Staphylococcus aureus from blood cultures.
Jung SI; Shin DH; Park KH; Shin JH
J Microbiol; 2006 Jun; 44(3):336-43. PubMed ID: 16820764
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
[TBL] [Abstract][Full Text] [Related]
10. Characterization of community-acquired Staphylococcus aureus infections in children.
Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
[TBL] [Abstract][Full Text] [Related]
11. The evolution of Staphylococcus aureus.
Deurenberg RH; Stobberingh EE
Infect Genet Evol; 2008 Dec; 8(6):747-63. PubMed ID: 18718557
[TBL] [Abstract][Full Text] [Related]
12. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital.
Huang YH; Tseng SP; Hu JM; Tsai JC; Hsueh PR; Teng LJ
Clin Microbiol Infect; 2007 Jul; 13(7):717-24. PubMed ID: 17403129
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
Brown PD; Ngeno C
Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
[TBL] [Abstract][Full Text] [Related]
15. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
Maeda Y; Loughrey A; Earle JA; Millar BC; Rao JR; Kearns A; McConville O; Goldsmith CE; Rooney PJ; Dooley JS; Lowery CJ; Snelling WJ; McMahon A; McDowell D; Moore JE
Complement Ther Clin Pract; 2008 May; 14(2):77-82. PubMed ID: 18396250
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
Al-Shawwa BA; Wegner D
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
Mendes RE; Sader HS; Deshpande L; Jones RN
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):433-6. PubMed ID: 18068326
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
